Intracellular tracing of amyloid vaccines through direct fluorescent labelling

Alzheimer’s disease is a debilitating neurodegenerative condition that progressively causes synaptic loss and major neuronal damage. Immunotherapy utilising Aβ as an active immunogen or via passive treatment utilising antibodies raised to amyloid have shown therapeutic promise. The migratory propert...

Descripción completa

Detalles Bibliográficos
Autores principales: Mold, Matthew, Kumar, Manpreet, Mirza, Ambreen, Shardlow, Emma, Exley, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799327/
https://www.ncbi.nlm.nih.gov/pubmed/29402930
http://dx.doi.org/10.1038/s41598-018-20845-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799327/
https://www.ncbi.nlm.nih.gov/pubmed/29402930
http://dx.doi.org/10.1038/s41598-018-20845-9

Ejemplares similares